Glycemic control and self-monitoring of blood glucose in Chinese patients with type 2 diabetes on insulin: Baseline results from the COMPASS study
作者: L JiQ SuB FengZ ShanR HuX XingY Xue
作者单位: 1Peking University People's Hospital, Beijing, China
2Xin Hua Hospital, Shanghai, China
3Tongji University Oriental Hospital, Shanghai, China
4The First Hospital of China Medical University, Shenyang, Liaoning, China
5Huashan Hospital, Shanghai, China
6Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China
7Nan Fang Hospital, Guangzhou, Guangdong, China
刊名: Diabetes Research and Clinical Practice, 2016, Vol.112 , pp.82-87
来源数据库: Elsevier Journal
DOI: 10.1016/j.diabres.2015.08.005
关键词: Type 2 diabetesInsulinSMBG
原始语种摘要: Abstract(#br)Aims(#br)Self monitoring of blood glucose (SMBG) is not widely utilized in insulin-treated patients with type 2 diabetes. In this analysis, we evaluated the current state of SMBG in Chinese adults with type 2 diabetes treated with insulin.(#br)Methods(#br)The 2-phase COMPASS study involved 24 centers across 10 provinces and cities in China. In the first phase, a cross sectional survey was carried out in type 2 diabetes patients receiving insulin treatment. The inclusion criteria for the study subjects in the first phase were: type 2 diabetes, insulin treatment for ≥3 months, and age ≥18 years. Evaluation was made on the status of SMBG and insulin therapy in these patients by a questionnaire.(#br)Results(#br)A total of 2819 patients (age 58.2±...
全文获取路径: Elsevier  (合作)
分享到:
来源刊物:
影响因子:2.741 (2012)

×